Human Clinical Trials Confirm Mulbalance® Mulberry Leaf Extract Efficacy in Body Fat and Blood Lipid Management

Striving for excellence and backing it up with science. 

Following our previous human clinical trial on blood glucose management, ACE Biotechnology has reached another major milestone in product research and development: a new human clinical trial evaluating the efficacy of Mulbalance® Mulberry Leaf Extract，led by an independent third-party clinical laboratory，has concluded with resounding success, with all primary endpoints achieving statistical significance.

To comprehensively evaluate the actual performance of the product, this rigorous trial spanned 8 weeks and tracked multi-dimensional physiological indicators across 76 participants. The trial results are as follows:

lBody Fat Mass: Decreased by an average of 1.09kg

lSubcutaneous Fat Thickness：Decreased by 1.68mm

lBody Weight: Decreased by an average of 0.99kg

lWaist Circumference: Decreased by an average of 1.22cm

lHip Circumference: Decreased by an average of 0.47cm

lBMI: Decreased by an average of 0.38

lTG:  Decreased by 0.18mmol/L

lLDL-C: Decreased by 0.17mmol/L

lTC & HDL-C: Remained stable with no adverse fluctuations.

lHigh Tolerability & Safety: Exhibited excellent biocompatibility with no adverse events reported throughout the study duration.

This breakthrough achievement further validates the robust, evidence-based efficacy of ACE Biotechnology's botanical extract. And our mission is to become our business partners' first choice that is reliable, innovative, competitive and continually-improving.

Explore Product Details and Discover Science-Backed Wellness.